GMED vs. EW
Compare and contrast key facts about Globus Medical, Inc. (GMED) and Edwards Lifesciences Corporation (EW).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GMED or EW.
Key characteristics
| GMED | EW | |
|---|---|---|
| YTD Return | 52.19% | -13.23% |
| 1Y Return | 77.04% | -1.27% |
| 3Y Return (Ann) | 4.65% | -17.28% |
| 5Y Return (Ann) | 8.12% | -4.18% |
| 10Y Return (Ann) | 13.74% | 12.17% |
| Sharpe Ratio | 2.30 | 0.01 |
| Sortino Ratio | 3.64 | 0.30 |
| Omega Ratio | 1.48 | 1.06 |
| Calmar Ratio | 1.61 | 0.01 |
| Martin Ratio | 16.40 | 0.03 |
| Ulcer Index | 4.64% | 17.55% |
| Daily Std Dev | 33.07% | 41.40% |
| Max Drawdown | -47.91% | -54.32% |
| Current Drawdown | -3.52% | -49.37% |
Fundamentals
| GMED | EW | |
|---|---|---|
| Market Cap | $11.36B | $39.34B |
| EPS | $0.62 | $2.55 |
| PE Ratio | 134.55 | 25.81 |
| PEG Ratio | 2.17 | 6.08 |
| Total Revenue (TTM) | $2.48B | $5.87B |
| Gross Profit (TTM) | $1.38B | $4.57B |
| EBITDA (TTM) | $366.24M | $1.70B |
Correlation
The correlation between GMED and EW is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GMED vs. EW - Performance Comparison
In the year-to-date period, GMED achieves a 52.19% return, which is significantly higher than EW's -13.23% return. Over the past 10 years, GMED has outperformed EW with an annualized return of 13.74%, while EW has yielded a comparatively lower 12.17% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GMED vs. EW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GMED vs. EW - Dividend Comparison
Neither GMED nor EW has paid dividends to shareholders.
Drawdowns
GMED vs. EW - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum EW drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for GMED and EW. For additional features, visit the drawdowns tool.
Volatility
GMED vs. EW - Volatility Comparison
Globus Medical, Inc. (GMED) has a higher volatility of 10.63% compared to Edwards Lifesciences Corporation (EW) at 5.89%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GMED vs. EW - Financials Comparison
This section allows you to compare key financial metrics between Globus Medical, Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities